CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...

Intuitive Surgical stock tumbled Wednesday after the robotic surgery giant issued a lackluster view for 2026 procedure growth ...

ISRG posts strong preliminary Q4 and full-year 2025 revenue growth, but shares dip as investors weigh procedure trends, ...

Should you buy stock in Intuitive Surgical right now? Before you buy stock in Intuitive Surgical, consider this: The Motley ...

Intuitive Surgical Q4 2025 revenue rose 19% y/y; 2026 procedure guidance disappointed, but da Vinci 5 strength supports ...

One stock that seems to fit the bill is Intuitive Surgical (NASDAQ: ISRG). This robotic surgery pioneer gained 8% in 2025 -- ...

Intuitive reported preliminary FY25 revenues of around $10.06bn, reflecting a 21% increase on $8.35bn in FY24.

That said, even after a 30% drawdown, the stock is unlikely to appear cheap on an absolute level. Unless the growth story ...

Intuitive, a leader in robotic-assisted surgery (RAS), announced two studies showing that RAS improves access to high-quality care and enhances patient outcomes, particularly in areas with limited ...

Despite the revenue beat, investors appeared concerned about a slowdown in Ion endoluminal system placements, which fell to 42 in the fourth quarter compared to 69 in the same period last year. The ...

Intuitive, a leader in robotic-assisted surgery, showcased its telesurgery capabilities during the Society of Robotic Surgery conference in Strasbourg, France, by connecting two surgeons across the ...